a study on Crohn's Disease Inflammatory Bowel Disease
This is a open-label extension (OLE) study designed to evaluate the long-term efficacy, safety, and tolerability of ABT-494.
A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of ABT-494 in Subjects With Crohn's Disease
Crohn's Disease (CD) Crohn's Disease Tolerability ABT-494 Efficacy Safety
Open to people ages 18 years to 75 years
© 2017 The Regents of the University of California